- Poster presentation
- Published:
Reduced responsiveness of blood leukocytes to lipopolysaccharide does not predict nosocomial infections in critically ill patients
Critical Care volume 19, Article number: P38 (2015)
Introduction
Critically ill patients show signs of immune suppression, which is considered to increase vulnerability to nosocomial infections. Whole blood stimulation is a frequently used functional test for immune suppression. We here aimed to assess the association between whole blood leukocyte responsiveness to lipopolysaccharide (LPS) and the subsequent occurrence of nosocomial infections in critically ill patients admitted to the ICU.
Methods
All consecutive critically ill patients admitted to the ICU between April 2012 and June 2013 with two or more systemic inflammatory response syndrome criteria and an expected length of ICU stay of more than 24 hours were enrolled. Age-matched and gender-matched healthy individuals were included as controls. Blood was drawn the first morning after ICU admission and stimulated ex vivo with 100 ng/ml ultrapure LPS for 3 hours. Tumor necrosis factor (TNF)-α, interleukin (IL)-1β and IL-6 were measured in supernatants.
Results
Seventy-three critically ill patients were included, 10 of whom developed an ICU-acquired infection. Compared with healthy subjects, whole blood leukocytes of patients were less responsive to ex vivo stimulation with LPS, as reflected by strongly reduced TNFα, IL-1β and IL-6 levels in culture supernatants. However, results were not different between patients who did and those who did not develop an ICU-acquired infection (Figure 1).
Conclusion
The extent of reduced LPS responsiveness of blood leukocytes in critically ill patients on the first day after ICU admission does not relate to the subsequent development of ICU-acquired infections.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Van Vught, L., Wiewel, M., Hoogendijk, A. et al. Reduced responsiveness of blood leukocytes to lipopolysaccharide does not predict nosocomial infections in critically ill patients. Crit Care 19 (Suppl 1), P38 (2015). https://doi.org/10.1186/cc14118
Published:
DOI: https://doi.org/10.1186/cc14118